Abstract
Fear of progression (or fear of recurrence) is an appropriate, adequate response to the real threat of cancer. However, elevated levels of fear of progression can become dysfunctional, affecting well-being, quality of life, and social functioning. Research has shown that fear of progression is one of the most frequent distress symptoms of patients with cancer. As a clear consensus concerning clinically relevant states of fear of progression is still lacking, it is difficult to provide a valid estimate of the rate of cancer patients who clearly suffer from fear of progression. Current evidence suggests that probably 50% of cancer survivors experience moderate to severe fear of progression. Furthermore, many patients express unmet needs in dealing with the fear of cancer spreading. These results underscore the need to provide effective psychological treatments for clinical states of fear of progression. Some psychosocial interventions for treating fear of progression have been developed. Our own, targeted intervention study showed that clinical fear of progression can be effectively treated with brief group therapy.
This is an updated version of the chapter: Herschbach P, Dinkel A (2014) Fear of progression. In: Goerling U (Ed). Psycho-Oncology (Recent Results in Cancer Research 197). Berlin: Springer; p. 11-29.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Armes J, Crowe M, Colbourne L et al (2009) Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal study. J Clin Oncol 27:6172–6179
Beck AT, Steer RA (1993) Beck anxiety inventory. Manual. Psychological Corporation, San Antonio
Berg P, Book K, Dinkel A et al (2011) Progredienzangst bei chronischen Erkrankungen [Fear of progression in chronic diseases]. Psychother Psychosom Med Psychol 61:32–37
Butow PN, Bell ML, Smith AB et al (2013) Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer 13:201
Crist JV, Grunfeld EA (2013) Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology 22:978–986
Dankert A, Duran G, Engst-Hastreiter U et al (2003) Progredienzangst bei Patienten mit Tumorerkrankungen, Diabetes mellitus und entzündlich-rheumatischen Erkrankungen [Fear of progression in patients with cancer, diabetes mellitus and chronic arthritis]. Rehabilitation 42:155–163
Dieng M, Butow PN, Costa DS et al (2016) Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primary melanoma: results of a randomized controlled trial. J Clin Oncol 34:4405–4414
Dinkel A, Herschbach P, Berg P et al (2012) Determinants of long-term response to group therapy for dysfunctional fear of progression in chronic diseases. Behav Med 38:1–5
Dinkel A, Kremsreiter K, Marten-Mittag B et al (2014) Comorbidity of fear of progression and anxiety disorders in cancer patients. Gen Hosp Psychiatry 36:613–619
Fardell JE, Thewes B, Turner J et al (2016) Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation. J Cancer Surviv 10:663–673
Fidika A, Herle M, Herschbach P et al (2015) Fear of disease progression questionnaire for parents: psychometric properties based on a sample of caregivers of children and adolescents with cystic fibrosis. J Psychosom Res 79:49–54
Fisher A, Beeken RJ, Heinrich M et al (2016) Health behaviours and fear of cancer recurrence in 10 969 colorectal cancer (CRC) patients. Psycho-Oncology 25:1434–1440
Ghazali N, Cadwallader E, Lowe D et al (2013) Fear of recurrence among head and neck cancer survivors: longitudinal trends. Psycho-Oncology 22:807–813
Gurevich M, Devins GM, Rodin GM (2002) Stress response syndromes and cancer: conceptual and assessment issues. Psychosomatics 43:259–281
Halbach SM, Enders A, Kowalski C et al (2016) Health literacy and fear of cancer progression in elderly women newly diagnosed with breast cancer—a longitudinal analysis. Patient Educ Couns 99:855–862
Harrison JD, Young JM, Price MA et al (2009) What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer 17:1117–1128
Heinrichs N, Zimmermann T, Huber B et al (2012) Cancer distress reduction with a couple-based skills training: a randomized controlled trial. Ann Behav Med 43:239–252
Herschbach P, Berg P, Dankert A et al (2005) Fear of progression in chronic diseases. Psychometric properties of the fear of progression questionnaire (FoP-Q). J Psychosom Res 58:505–511
Herschbach P, Berg P, Waadt S et al (2010a) Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychother Psychosom 79:31–38
Herschbach P, Book K, Dinkel A et al (2010b) Evaluation of two group therapies to reduce fear of progression in cancer patients. Support Care Cancer 18:471–479
Herschbach P, Keller M, Knight L et al (2004) Psychological problems of cancer patients: a cancer distress screening with a cancer-specific questionnaire. Br J Cancer 91:504–511
Hinz A, Mehnert A, Ernst J et al (2015) Fear of progression in patients 6 months after cancer rehabilitation—a validation study of the fear of progression questionnaire FoP-Q-12. Support Care Cancer 23:1579–1587
Hodges LJ, Humphris GM (2009) Fear of recurrence and psychological distress in head and neck cancer patients and their carers. Psychooncology 18:841–848
Hoyer J, Beesdo K, Gloster AT et al (2009) Worry exposure versus applied relaxation in the treatment of generalized anxiety disorder. Psychother Psychosom 78:106–115
Humphris G, Ozakinci G (2008) The AFTER intervention: a structured psychological approach to reduce fear of recurrence in patients with head and neck cancer. Br J Health Psychol 13:223–230
Kanatas A, Ghazali N, Lowe D et al (2013) Issues patients would like to discuss at their review consultation: variation by early and late stage oral, oropharyngeal and laryngeal subsites. Eur Arch Otorhinolaryngol 270:1067–1074
Kim Y, Carver CS, Spillers RL et al (2012) Dyadic effects of fear of recurrence on the quality of life of cancer survivors and their caregivers. Qual Life Res 21:517–525
Koch L, Jansen L, Brenner H et al (2013) Fear of recurrence and disease progression in long-term (≥5 years) cancer survivors—a systematic review of quantitative studies. Psycho-Oncology 22:1–11
Koch-Gallenkamp L, Bertram H, Eberle A et al (2016) Fear of recurrence in long-term cancer survivors—do cancer type, sex, time since diagnosis, and social support matter? Health Psychol 35:1329–1333
Kwakkenbos L, van den Hoogen FHJ, Custers J et al (2012) Validity of the fear of progression questionnaire-short form in patients with systemic sclerosis. Arthritis Care Res 64:930–934
Lebel S, Maheu C, Lefebvre M et al (2014) Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Surviv 8:485–496
Lebel S, Ozakinci G, Humphris G et al (2016) From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer 24:3265–3268
Lebel S, Ozakinci G, Humphris G et al (2017) Current state and future prospects of research on fear of cancer recurrence. Psycho-Oncology 26:424–427
Lebel S, Tomei C, Feldstain A et al (2013) Does fear of recurrence predict cancer survivors health care use? Support Care Cancer 21:901–906
Lee-Jones C, Humphris G, Dixon R et al (1997) Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psycho-Oncology 6:95–105
Lengacher CA, Johnson-Mallard V, Post-White J et al (2009) Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psycho-Oncology 18:1261–1272
Lengacher CA, Reich RR, Paterson CL et al (2016) Examination of broad symptom improvement resulting from mindfulness-based stress reduction in breast cancer survivors: a randomized controlled trial. J Clin Oncol 34:2827–2834
Maheu C, Lebel S, Courbasson C et al (2016) Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer. BMC Cancer 16:291
Mehnert A, Berg P, Henrich G et al (2009) Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psycho-Oncology 18:1273–1280
Mehnert A, Brähler E, Faller H et al (2014) Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol 32:3540–3546
Mehnert A, Herschbach P, Berg P et al (2006) Progredienzangst bei Brustkrebspatientinnen—Validierung der Kurzform des Progredienzangst-fragebogens PA-F-KF [Fear of progression in breast cancer patients—validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)]. Z Psychosom Med Psychother 52:274–288
Mehnert A, Koch U, Sundermann C et al (2013) Predictors of fear of recurrence in patients one year after cancer rehabilitation: a prospective study. Acta Oncol. doi:10.3109/0284186X.2013.765063
Mellon S, Kershaw TS, Northouse LL et al (2007) A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psycho-Oncology 16:214–223
Mitchell AJ, Chan M, Bhatti H et al (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12:160–174
Moorey S (1996) When bad things happen to rational people: cognitive therapy in adverse life circumstances. In: Salkovskis PM (ed) Frontiers of cognitive therapy. Guilford, New York, pp 450–469
Myers SB, Manne SL, Kissane DW et al (2013) Social-cognitive processes associated with fear of recurrence among women newly diagnosed with gynecological cancers. Gynecol Oncol 128:120–127
NCCN Guideline Distress Management, Version 2.2103. http://www.nccn.org/professionals/physician_gls/pdf/distress.pdf. Accessed 01 June 2013
Northouse LL (1981) Mastectomy patients and the fear of cancer recurrence. Cancer Nurs 4:213–220
Rogers SN, El-Sheikha J, Lowe D (2009) The development of a Patients Concerns Inventory (PCI) to help reveal patients concerns in the head and neck clinic. Oral Oncol 45:555–561
Rudolph B, Wünsch A, Herschbach P et al (2017) Ambulante verhaltenstherapeutische Gruppentherapie zur Behandlung von Progredienzangst bei Krebspatienten [Cognitive-behavioral group therapy addressing fear of progression in cancer outpatients]. Psychother Psychosom Med Psychol. doi:10.1055/s-0043-107774
Sabariego C, Brach M, Herschbach P et al (2011) Cost-effectiveness of cognitive-behavioral group therapy of dysfunctional fear of progression in cancer patients. Eur J Health Econ 12:489–497
Salander P (2010) Motives that cancer patients in oncological care have for consulting a psychologist—an empirical study. Psycho-Oncology 19:248–254
Savard J, Ivers H (2013) The evolution of fear of cancer recurrence during the cancer care trajectory and its relationship with cancer characteristics. J Psychosom Res 74:354–360
Schepper F, Abel K, Herschbach P et al (2015) Progredienzangst bei Eltern krebskranker Kinder: Adaptation eines Fragebogens und Korrelate [Fear of progression in parents of children with cancer: adaptation of the Fear of Progression Questionnaire and correlates]. Klin Pädiatr 227:151–156
Shim EJ, Shin YW, Oh DY et al (2010) Increased fear of progression in cancer patients with recurrence. Gen Hosp Psychiatry 32:169–175
Simard S, Savard J (2009) Fear of Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17:241–251
Simard S, Savard J (2015) Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv 9:481–491
Simard S, Thewes B, Humphris G et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7:300–322
Simonelli LE, Siegel SC, Duffy NM (2016) Fear of cancer recurrence: a theoretical review and its relevance for clinical presentation and management. Psycho-Oncology. doi:10.1002/pon.4168
Singer S, Das-Munshi J, Brähler E (2010) Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis. Ann Oncol 21:925–930
Skaali T, Fosså SD, Bremnes R et al (2009) Fear of recurrence in long-term testicular cancer survivors. Psychooncology 18:580–588
Smith AB, Thewes B, Turner J et al (2015) Pilot of a theoretically grounded psychologist-delivered intervention for fear of cancer recurrence (Conquer Fear). Psycho-Oncology 24:967–970
Spielberger CD, Gorsuch RL, Lushene R et al (1983) Manual for the state-trait anxiety inventory. Consulting Psychologists Press, Palo Alto
Thewes B, Butow P, Bell ML et al (2012a) Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviors. Support Care Cancer 20:2651–2659
Thewes B, Butow P, Zachariae R et al (2012b) Fear of cancer recurrence: a systematic literature review of self-report measures. Psycho-Oncology 21:571–587
van de Wal M, Gielissen MFM, Servaes P et al (2015) Study protocol of the SWORD-study: a randomised controlled trial comparing combined online and face-to-face cognitive behaviour therapy versus treatment as usual in managing fear of cancer recurrence. BMC Psychology 3:12
van de Wal M, van de Poll-Franse L, Prins J et al (2016) Does fear of cancer recurrence differ between cancer types? A study from the population-based PROFILES registry. Psycho-Oncology 25:772–778
van Helmondt SJ, van der Lee ML, de Vries J (2016) Study protocol of the CAREST-trial: a randomised controlled trial on the (cost-) effectiveness of a CBT-based online self-help training for fear of cancer recurrence in women with curatively treated breast cancer. BMC Cancer 16:527
Vehling S, Koch U, Ladehoff N et al (2012) Prävalenz affektiver und Angststörungen bei Krebs: Systematischer Literaturreview und Metaanalyse [Prevalence of affective and anxiety disorders in cancer: systematic literature review and meta-analysis]. Psychother Psychosom Med Psychol 62:249–258
Vickberg SMJ (2003) The concerns about recurrence scale (CARS): a systematic measure of women’s fears about the possibility of breast cance recurrence. Ann Behav Med 25:16–24
Waadt S, Duran G, Berg P et al (2011) Progredienzangst. Manual zur Behandlung von Zukunftsängsten bei chronisch Kranken [Fear of Progression. Treatment manual]. Schattauer, Stuttgart
Zimmermann T, Alsleben M, Heinrichs N (2012) Progredienzangst gesunder Lebenspartner von chronisch erkrankten Patienten [Fear of progression in partners of chronically ill patients]. Psychother Psychosom Med Psychol 62:344–351
Zimmermann T, Herschbach P, Wessarges M et al (2011) Fear of progression in partners of chronically ill patients. Behav Med 37:95–104
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Dinkel, A., Herschbach, P. (2018). Fear of Progression in Cancer Patients and Survivors. In: Goerling, U., Mehnert, A. (eds) Psycho-Oncology. Recent Results in Cancer Research, vol 210. Springer, Cham. https://doi.org/10.1007/978-3-319-64310-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-64310-6_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-64309-0
Online ISBN: 978-3-319-64310-6
eBook Packages: MedicineMedicine (R0)